Literature DB >> 16899426

Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.

E I Brokalaki1, M Hentschke, S Grabbe, T Jansen.   

Abstract

Fabry disease is an X-linked lysosomal disorder caused by deficiency of the lysosomal enzyme alpha-galactosidase A. We report on a 32-year-old female patient with an 8-year history of vascular lesions on the hips and periumbilical region and a presumed Fabry disease without positive family history. Ophthalmologic evaluation revealed whorl-like corneal opacities. Echocardiography revealed myxomatous degeneration and prolapse of the mitral valve. DNA analysis of the alpha-galactosidase A gene confirmed the diagnosis of Fabry disease, showing a de novo point mutation at position 691 of exon 5. The patient is now obtaining intravenous enzyme replacement therapy with agalsidase alfa and remains without drug-related reactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899426

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  4 in total

1.  De novo mutation in a male patient with Fabry disease: a case report.

Authors:  Francesco Iemolo; Federica Pizzo; Giuseppe Albeggiani; Carmela Zizzo; Paolo Colomba; Simone Scalia; Caterina Bartolotta; Giovanni Duro
Journal:  BMC Res Notes       Date:  2014-01-07

2.  Frequency of de novo mutations in Japanese patients with Fabry disease.

Authors:  Masahisa Kobayashi; Toya Ohashi; Sayoko Iizuka; Eiko Kaneshiro; Takashi Higuchi; Yoshikatsu Eto; Hiroyuki Ida
Journal:  Mol Genet Metab Rep       Date:  2014-08-02

3.  A New De Novo Genetic Mutation of Fabry Disease in a Young Indian Male.

Authors:  Sree Bhushan Raju; Alok Sharma; Anvesh Golla
Journal:  Indian J Nephrol       Date:  2022-07-16

4.  Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease.

Authors:  Antonio Pisani; Aurora Daniele; Carmela Di Domenico; Ersilia Nigro; Francesco Salvatore; Eleonora Riccio
Journal:  BMC Res Notes       Date:  2015-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.